Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

Findings of a study comparing waist circumference to BMI for predicting the development of obesity-related cancers show that waist circumference is a stronger risk marker in men but not in women.

The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors' perception of the ...

What is obesity? Here's what you need to know about the disease expected to impact 50% of adults worldwide by 2050.

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many ...

In countless reports and studies, obesity is often reduced to just a number: 42% of adults in the U.S. have obesity, ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

With the advent of GLP-1 drugs, perspectives about weight management are changing. Ted Kyle hopes the food industry can make some changes, too, to better serve all consumers.

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...